These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8396563)

  • 21. Safrole in betel quid may be a risk factor for hepatocellular carcinoma: case report.
    Liu CJ; Chen CL; Chang KW; Chu CH; Liu TY
    CMAJ; 2000 Feb; 162(3):359-60. PubMed ID: 10693594
    [No Abstract]   [Full Text] [Related]  

  • 22. Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma.
    Wanless IR
    Am J Gastroenterol; 1996 May; 91(5):836-7. PubMed ID: 8633567
    [No Abstract]   [Full Text] [Related]  

  • 23. East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma.
    Desmet VJ
    Hepatology; 2009 Feb; 49(2):355-7. PubMed ID: 19127518
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatocellular carcinoma--carcinogenesis updated.
    Yap I
    Singapore Med J; 1995 Dec; 36(6):597-9. PubMed ID: 8781628
    [No Abstract]   [Full Text] [Related]  

  • 25. The application of image analysis and neural network technology to the study of large-cell liver-cell dysplasia and hepatocellular carcinoma.
    An CS; Petrovic LM; Reyter I; Tolmachoff T; Ferrell LD; Thung SN; Geller SA; Marchevsky AM
    Hepatology; 1997 Nov; 26(5):1224-31. PubMed ID: 9362366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preneoplastic cellular changes in liver.
    Borzio M; Roncalli M; Treré D; Derenzini M
    Hepatology; 1998 Nov; 28(5):1435. PubMed ID: 9794934
    [No Abstract]   [Full Text] [Related]  

  • 27. Some emerging general principles in the pathogenesis of hepatocellular carcinoma.
    Farber E
    Cancer Surv; 1986; 5(4):695-718. PubMed ID: 3040241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.
    Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R
    Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correspondence re: Chieco P, Van Noorden C. Letter to the editor [in re Rubin EM, Derose PB, Cohen C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol 1994;7:677]. Mod Pathol 1996;9:84-5.
    Gschwendtner A; Mairinger T
    Mod Pathol; 1997 Jan; 10(1):84-5. PubMed ID: 9021731
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent advances in the natural history of hepatocellular carcinoma.
    Trevisani F; Cantarini MC; Wands JR; Bernardi M
    Carcinogenesis; 2008 Jul; 29(7):1299-305. PubMed ID: 18515282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of the relationship between irregular regeneration and two hepatocarcinogenic pathways: "de novo" and so-called "dysplastic nodule-hepatocellular carcinoma" sequence.
    Taguchi K; Aishima S; Matsuura S; Terashi T; Nishiyama K; Shirabe K; Shimada M; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2005 Nov; 92(2):100-3. PubMed ID: 16231367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma.
    Hino O; Kajino K; Umeda T; Arakawa Y
    J Gastroenterol; 2002; 37(11):883-7. PubMed ID: 12483242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Premalignant lesions of hepatocellular carcinoma].
    Nakano M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():216-21. PubMed ID: 11761943
    [No Abstract]   [Full Text] [Related]  

  • 35. [Establishment and characterization of human extrahepatic growing hepatocellular carcinoma cell line EGHC-9901].
    Wu X; Wang Z; Liu B; Liu J; Gao Y; Li Z; Liu C
    Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):616-7. PubMed ID: 12417079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y; Takeda S; Takagi H
    Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver polyploidy: Dr Jekyll or Mr Hide?
    Gentric G; Desdouets C
    Oncotarget; 2015 Apr; 6(11):8430-1. PubMed ID: 25940698
    [No Abstract]   [Full Text] [Related]  

  • 38. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
    Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular events in hepatic preneoplasia: a review.
    French SW
    Exp Mol Pathol; 2010 Apr; 88(2):219-24. PubMed ID: 20097196
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interview: questions to Professor Paulette Bioulac-Sage].
    Bioulac-Sage P
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1112-4. PubMed ID: 11139679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.